Evidence-graded · Source-cited Peer-reviewer panel · 6 clinicians
PeptideVox
Editorial standards

Editorial Policy

Last updated June 30, 2026

PeptideVox is an independent publication covering peptide therapeutics and human peptides for health-engaged adults, athletes, longevity seekers, and clinicians researching peptide therapies. This policy describes the standards that govern our reporting, our guides, and our recommendations.

Independence

Our coverage is editorially independent. Editorial decisions are made on the merits — what is accurate, important, and useful to our readers — and are not determined by advertisers, partners, or any commercial relationship. When we cover a company, product, or platform, that coverage is not for sale.

Sourcing and verification

We build reporting from primary sources wherever possible — research papers, regulatory filings, product documentation, on-the-record statements, and credible first-hand reporting. We:

Accuracy and corrections

We work to get things right the first time, and we fix mistakes promptly and transparently when we do not. If you believe we have published an error, please tell us — see our Corrections Policy for how we review and resolve them.

Analysis and opinion

Some pieces include analysis or informed judgment about what a development means. Where we offer a view, we ground it in the evidence and make the reasoning clear, so readers can weigh it for themselves. Our coverage is general information and commentary, not professional advice.

Commercial relationships

PeptideVox may earn revenue through advertising, sponsorships, or other commercial arrangements. These are kept separate from editorial judgment, and they do not buy favorable coverage or influence our assessments, rankings, or recommendations.

Guides and recommendations

Our guides and rankings are built against stated criteria, are honest about trade-offs, and are reviewed and refreshed to keep pricing, features, and recommendations current. We aim to help readers choose well, not to push any single product.

Feedback

We welcome questions, tips, and challenges to our reporting. Email editor@peptidevox.com.

Medical Disclaimer · Read in full

PeptideVox is an evidence reference, not medical advice. Nothing here authorizes you to acquire, possess, or self-administer any compound.

01 · Not FDA-approved

The majority of compounds documented here are not approved by the FDA for human use. Approved drugs (e.g. semaglutide, tirzepatide) are noted explicitly and require a licensed prescriber.

02 · Research chemicals

Many peptides — including BPC-157 and GHK-Cu in injectable form — are sold strictly "for research use only — not for human consumption." Purity, identity, and dosing of such products are not regulated or guaranteed.

03 · WADA-prohibited

Several compounds are banned in competitive sport under the WADA Prohibited List. Athletes risk sanction regardless of intent or formulation.

04 · Consult a clinician

Always consult a qualified, licensed healthcare professional before considering any compound. Individual risk depends on your full medical context.

This content is for informational and educational purposes only · No physician–patient relationship is created · Evidence grades reflect published data as of the stated revision and may change.